However, the amount of Covid vaccine exported will be determined monthly by the government so that domestic availability is not compromised.
India recently resumed the supply of Covid vaccine to UN-sponsored COVAX, and the government has allowed the Serum Institute of India (SII) to export 50-rak Covishield to Nepal, Tajikistan, Bangladesh and Mozambique.
Covishield shipments will arrive in Nepal and Tajikistan this week.
“The balance of 22.72 chlores and the dose of unused COVID-19 vaccine is still available in state and Union territory. Vaccine production is increasing and there is a surplus supply.
“With this in mind, a decision was made to permit commercial exports of the Covishield and Covaxin,” official sources told PTI.
Prakash Kumar Singh, SII’s head of government and regulation, recently told the Federal Ministry of Health that the Pune-based company has administered 24,89,15,000 Covishield doses and inventories are increasing daily. ..
But officials emphasized that “the amount of vaccines exported will be determined monthly by the government to ensure that domestic availability is never compromised.”
A dose of about 31 chlores of Covishield and Covaxin is expected to be received by the government from SII and Bharat Biotech in December, while Zydus Cadila is a jab of about 2 chlores of 3 doses of the Covid vaccine ZyCoV-D by that time. May be supplied.
The government recently licensed a two-chlor dose of the COVID-19 vaccine Covovax produced in India by SII to Indonesia. According to official sources, the jab has not yet been approved for emergency use in the country.
The first shipment of Covovax will arrive in Indonesia this week.
Government favors commercial exports of Covishield, Covacin, Health News, ET Health World, considering sufficient inventories
Source link Government favors commercial exports of Covishield, Covacin, Health News, ET Health World, considering sufficient inventories